Pay in 4 interest-free payments of $6.54 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
Developed by Metabolic Pharmaceuticals in Australia, AOD-9604 was engineered to retain the fat-reducing properties of intact growth hormone while eliminating the undesirable effects on glucose metabolism, insulin sensitivity, and tissue growth
Combining the two: the practical protocol Here is where the combination protocol differs from running either compound alone
So far, AOD-9604 has not been shown to produce the same IGF-1 response
Stk528649 242
The compound can be used by women, though effects specific to female physiology have not been specifically studied
Structure, identifiers, and physical data are cataloged in curated chemical databases and supplier technical sheets [57]
US$ 22.43
US$ 27.89
US$ 22.31
US$ 25.44
US$ 27.37
US$ 26.48
US$ 25.95
US$ 29.62
US$ 25.68
